Is a complete BDSX research report available?

No complete published report is available for Biodesix, Inc. (BDSX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Biodesix, Inc. (BDSX)

NASDAQ: BDSX · USD

$22.0

-0.32 (-1.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BDSX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	227.8M
Revenue (ttm)	96.1M
Net income (ttm)	-32M
EPS (ttm)	-$3.93
Shares out	10.4M
Volume	90,514
Beta	0.52
Price target	$30.8	+40.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 96.1M
Net income (ttm): -32M
EPS (ttm): -$3.93
Market cap: 227.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BDSX indicators

Market & fundamental data

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001439725
Company name	Biodesix, Inc.
Country	United States
Country code	US
Cusip	09075X207
Employees	334
Employees Change	61%
Employees Change Percent	22.34
Enterprise value	$275.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
Industry PE	42.85
Industry PE Fwd	26.1
IPO Date	2020-10-28
Isin	US09075X2071
Last refreshed	2026-07-25
Market cap	$227.8M
Market cap category	Micro-Cap
Price	$22
Price currency	USD
Rev Per Employee	287,712.57x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	8071
Symbol	BDSX
Website	https://www.biodesix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.03%
EV Sales Forward	2.39x
EV/Sales	2.87x
FCF yield	-11.02%
P/B ratio	24.35x
P/S ratio	2.37x
PS Forward	1.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-25.95%
EBITDA Margin	-20.1%
Gross margin	81.66%
Gross Profit	$78.5M
Gross Profit Growth	34.46%
Gross Profit Growth Q	46.97%
Gross Profit Growth3 Y	43.36%
Gross Profit Growth5 Y	20.65%
Net Income	$-32M
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Pretax Margin	-33.26%
Profit Margin	-33.26%
Profit Per Employee	$-95,680
ROA	-17.48
Roa5y	-25.95
ROCE	-31.11
ROE	-316.5
Roe5y	-320.2
ROIC	-20.06

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	159.11%
Cagr3y	-2.03%
Cagr5y	-35.59%
EPS Growth Quarters	3
EPS Growth Years	7
Revenue Growth	29.05x
Revenue Growth Q	42.3x
Revenue Growth Quarters	15x
Revenue Growth Years	3x
Revenue Growth3 Y	33.14x
Revenue Growth5 Y	6.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.06
Assets	$94.6M
Cash	$25.6M
Current Assets	$40.9M
Current Liabilities	$14.5M
Debt	$73.6M
Debt Equity	$8.06
Equity	$9.1M
Interest Coverage	-3.11
Liabilities	$85.5M
Long Term Assets	$53.7M
Long Term Liabilities	$71M
Net Cash	$-48M
Net Cash By Market Cap	$-21.07
Net Debt Equity	$5.26
Tangible Book Value	$-9.4M
Tangible Book Value Per Share	$-0.93
WACC	7.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.82
Inventory Turnover	13.55
Net Working Capital	$3.4M
Quick ratio	2.42
Working Capital	$26.4M
Working Capital Turnover	$4.5

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.97%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	158.95%
200-day SMA	12.39
3Y total return	-5.98%
50-day SMA	18.06
50-day SMA vs 200-day SMA	50over200
5Y total return	-88.91%
All Time High	639.8
All Time High Change	-96.56%
All Time High Date	2021-01-20
All Time Low	3.44
All Time Low Change	540.28%
All Time Low Date	2025-05-15
ATR	1.9
Beta	0.52
Beta1y	0.57
Beta2y	0.4
Ch YTD	223.5
High	23.8
High52	24.92
High52 Date	2026-07-01
High52ch	-11.7%
Low	22
Low52	5.26
Low52 Date	2026-01-09
Low52ch	318.25%
Ma50ch	21.85%
Price vs 200-day SMA	77.52%
RSI	59.17
RSI Monthly	50.34
RSI Weekly	64.99
Sharpe ratio	1.34x
Sortino ratio	2.49
Total Return	-14.97%
Tr YTD	223.5
Tr1m	14.82%
Tr1w	8.97%
Tr3m	120.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	5
Analyst Price Target Top	$34
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.89
Earnings Revenue Estimate	25,942,856x
Earnings Revenue Estimate Growth	29.6x
Operating Income	$-25.3M
Operating margin	-26.33
Price target	$30.83
Price Target Change	$40.14
Price Target Change Top	$54.55

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,806,854%
Float Percent	46.42%
Net Borrowing	9,981,000
Shares Insiders	41.19%
Shares Institutions	27.38%
Shares Out	10,355,809
Shares Qo Q	19.73%
Shares Yo Y	14.97%
Short Float	2.19%
Short Ratio	1.29
Short Shares	1.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-29.4M
Average Volume	82,664.3x
Bv Per Share	0.9
CAPEX	$-266,000
Ch1m	14.82
Ch1w	8.97
Ch1y	158.9
Ch3m	120.9
Ch3y	-5.98
Ch5y	-88.91
Ch6m	87.39
Change	-1.43%
Change From Open	0
Close	22.32
Days Gap	-1.43
Depreciation Amortization	5,626,000
Dollar Volume	1,991,308
Earnings Date	2026-08-05
Earnings Time	amc
EBIT	$-24.9M
EBITDA	$-19.3M
EPS	$-3.93
F Score	4
FCF	$-25.1M
FCF EV Yield	-9.1x
FCF Per Share	$-2.42
Financing CF	33,217,000
Fiscal Year End	December
Founded	2,005
Goodwill	15,031,000
Investing CF	-410,000
Ipr	22.22
Iprfo	-91.91
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Date	2025-09-15
Last Split Type	Reverse
Last10k Filing Date	2026-02-26
Ma150	14.05
Ma150ch	56.64%
Ma20	21.62
Ma20ch	1.74%
Net CF	7,970,000
Next Earnings Date	2026-08-05
Open	22
Optionable	Yes
Position In Range	0
Post Close	22
Postmarket Change Percent	-2
Postmarket Price	$21.56
Ppne	30,080,000
Price Date	2026-07-24
Relative Volume	1.09x
Revenue	96,096,000x
SBC By Revenue	4.46x
Share Based Comp	4,282,000
Tr6m	87.39%
Us State	Colorado
Volume	90,514
Z Score	-6.51

Biodesix, Inc. (BDSX)

Coverage state: Market snapshot only — no published research

Generate the first BDSX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BDSX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BDSX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BDSX

Frequently asked questions